Champions Oncology, Inc.
CSBRNasdaqCIK 771856HealthcareFiscal year ends Apr 30
Reports and events: 248 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1616:15 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-066087 |
| 2026-09-1118:51 ET | 10-Q | Quarterly reportPeriod 2026-07-31 | 0001628280-26-061519 |
| 2026-09-1020:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-061383 |
| 2026-08-2819:35 ET | DEF 14A | Proxy statementPeriod 2026-08-27 | 0001628280-26-059373 |
| 2026-07-2720:45 ET | 10-K | Annual reportPeriod 2026-04-30 | 0001628280-26-049834 |
| 2026-07-2720:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-049822 |
| 2026-03-3017:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-021941 |
| 2026-03-1220:56 ET | 10-Q | Quarterly reportPeriod 2026-01-31 | 0001628280-26-017345 |
| 2026-03-1220:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-017259 |
| 2025-12-1521:59 ET | 10-Q | Quarterly reportPeriod 2025-10-31 | 0001628280-25-057082 |
| 2025-12-1521:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-057020 |
| 2025-10-1621:05 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-045241 |
| 2025-09-1520:50 ET | 10-Q | Quarterly reportPeriod 2025-07-31 | 0000771856-25-000023 |
| 2025-09-1520:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000771856-25-000022 |
| 2025-08-2219:20 ET | DEF 14A | Proxy statementPeriod 2025-08-22 | 0000771856-25-000009 |
| 2025-07-2321:01 ET | 10-K | Annual reportPeriod 2025-04-30 | 0001628280-25-035765 |
| 2025-07-2320:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-035727 |
| 2025-07-2117:49 ET | 8-K | 9.01 Financial statements and exhibits | 0001628280-25-035424 |
| 2025-03-1715:03 ET | 10-Q | Quarterly reportPeriod 2025-01-31 | 0001628280-25-012941 |
| 2025-03-1120:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-012022 |
| 2024-12-1621:16 ET | 10-Q | Quarterly reportPeriod 2024-10-31 | 0001628280-24-051389 |
| 2024-12-1121:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-050789 |
| 2024-10-1513:43 ET | 8-K | 5.07 Shareholder vote results | 0001628280-24-042780 |
| 2024-10-0315:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-24-042039 |
| 2024-09-1317:07 ET | 10-Q | Quarterly reportPeriod 2024-07-31 | 0001628280-24-040312 |
| 2024-09-1120:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-040137 |
| 2024-08-2720:34 ET | DEF 14A | Proxy statementPeriod 2024-08-27 | 0001628280-24-038540 |
| 2024-07-1920:29 ET | 10-K | Annual reportPeriod 2024-04-30 | 0001628280-24-032321 |
| 2024-07-1820:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-032227 |
| 2024-05-0623:46 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-24-000427 |
| 2024-03-1521:37 ET | 10-Q | Quarterly reportPeriod 2024-01-31 | 0001628280-24-011279 |
| 2024-03-1220:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-010569 |
| 2023-12-1321:47 ET | 10-Q | Quarterly reportPeriod 2023-10-31 | 0001628280-23-041457 |
| 2023-12-1221:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-041308 |
| 2023-10-1920:32 ET | 8-K | 5.07 Shareholder vote results | 0001628280-23-034703 |
| 2023-10-1712:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-034475 |
| 2023-09-1321:18 ET | 10-Q | Quarterly reportPeriod 2023-07-31 | 0001628280-23-032212 |
| 2023-09-1320:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-032185 |
| 2023-08-2819:12 ET | DEF 14A | Proxy statementPeriod 2023-08-28 | 0001628280-23-030752 |
| 2023-07-2420:17 ET | 10-K | Annual reportPeriod 2023-04-30 | 0001628280-23-025464 |
| 2023-07-2420:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-025452 |
| 2023-04-0515:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-010813 |
| 2023-03-1618:03 ET | 10-Q | Quarterly reportPeriod 2023-01-31 | 0001628280-23-008251 |
| 2023-03-1519:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-008080 |
| 2022-12-1321:32 ET | 10-Q | Quarterly reportPeriod 2022-10-31 | 0001628280-22-031818 |
| 2022-12-1321:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-031796 |
| 2022-10-2015:21 ET | 8-K | 5.07 Shareholder vote results | 0001628280-22-026738 |
| 2022-09-1220:52 ET | 10-Q | Quarterly reportPeriod 2022-07-31 | 0001628280-22-024751 |
| 2022-09-0819:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-024587 |
| 2022-08-3113:29 ET | DEF 14A | Proxy statementPeriod 2022-08-29 | 0001628280-22-023938 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.